<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8-molecules-26-00461">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Scalas</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Mandras</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Roana</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Tardugno</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Cuffini</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Ghisetti</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Benvenuti</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tullio</surname>
    <given-names>V.</given-names>
   </name>
  </person-group>
  <article-title>Use of 
   <italic>Pinus sylvestris</italic> L. (Pinaceae), 
   <italic>Origanum vulgare</italic> L. (Lamiaceae), and 
   <italic>Thymus vulgaris</italic> L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible 
   <italic>Cryptococcus neoformans</italic> strains
  </article-title>
  <source>BMC Complement. Altern. Med.</source>
  <year>2018</year>
  <volume>18</volume>
  <elocation-id>143</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12906-018-2219-4</pub-id>
  <pub-id pub-id-type="pmid">29724221</pub-id>
 </element-citation>
</ref>
